Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Daiichi Sankyo
Daiichi Sankyo
Daiichi Sankyo moves further to cut legacy Ranbaxy ties
Fierce Pharma
Fri, 05/27/16 - 12:49 pm
Daiichi Sankyo
Ranbaxy
Daiichi snaps up Japanese rights to CVD stem-cell therapy
BioPharma Dive
Wed, 05/11/16 - 06:37 pm
Daiichi Sankyo
Japan
stem cells
Heartcel
Cell Therapy Group
Vermont governor slams AZ & Daiichi's OIC Super Bowl ad, calls for it to be pulled
BioPharma Dive
Fri, 02/12/16 - 04:22 pm
Vermont
AstraZeneca
Daiichi Sankyo
OIC
drug ads
Daiichi Sankyo shuts down a German R&D shop
Fierce Biotech
Tue, 12/8/15 - 10:50 pm
Daiichi Sankyo
Germany
R&D
Struggling Daiichi plots another 1,000-plus job cuts in U.S.
Fierce Pharma
Mon, 10/19/15 - 10:00 am
Daiichi Sankyo
layoffs
AstraZeneca uses snails and overstuffed luggage to push OIC awareness--and its branded solution
Fierce Pharma Marketing
Thu, 08/27/15 - 09:24 am
AstraZeneca
OIC
Monvantik
opiod-induced constipation
Daiichi Sankyo
Daiichi clot-buster wins a NICE green light, but still faces an uphill track
Fierce Biotech
Wed, 08/12/15 - 12:41 pm
Daiichi Sankyo
bloodthinners
Lixiana
edoxaban
NICE
Daiichi Sankyo cashing out after merging Ranbaxy with Sun
Fierce Pharma
Mon, 04/20/15 - 05:10 pm
Daiichi Sankyo
Ranbaxy
M&A
Sun Pharma
Daiichi Sankyo starts layoff drive with 16% cuts at HQ
Fierce Pharma
Mon, 03/23/15 - 12:09 pm
Daiichi Sankyo
layoffs
Daiichi shells out $200M-plus to help AstraZeneca launch Movantik
Fierce Pharma
Thu, 03/19/15 - 11:18 am
Daiichi Sankyo
AstraZeneca
Movantik
constipation
Drugmaker shifts sales model to keep pace with formulary decision making
Medical Marketing and Media
Thu, 02/26/15 - 04:47 pm
Daiichi Sankyo
formulary
Daiichi's new clot-fighter Savaysa can't make up for $2.6B Benicar patent loss: analysts
Fierce Biotech
Mon, 02/9/15 - 06:06 pm
Daiichi Sankyo
Savaysa
Benicar
patents
FDA warning for blockbuster hopeful edoxaban hits Daiichi where it hurts
BioPharma Dive
Mon, 02/9/15 - 11:08 am
FDA
warnings
Daiichi Sankyo
edoxaban
Daiichi Sankyo to pay $39 million to settle U.S. kickback claims: DOJ
Reuters
Sat, 01/10/15 - 12:40 pm
Daiichi Sankyo
legal
FDA Approves New Oral Anticoagulant From Daiichi Sankyo
Forbes
Thu, 01/8/15 - 10:17 pm
FDA
Daiichi Sankyo
bloodthinners
Savaysa
Indian merger creates fifth-largest generic drugmaker
Medical Marketing and Media
Mon, 12/8/14 - 11:23 pm
India
M&A
generics
Sun Pharma
Ranbaxy
Daiichi Sankyo
FDA Advisory Panel Gives Tepid Support To New Daiichi Sankyo Drug
Forbes
Fri, 10/31/14 - 02:01 pm
FDA
Daiichi Sankyo
advisory panels
bloodthinners
Savaysa
edoxaban
FDA staff recommends limited use of Daiichi's blood thinner
Yahoo/Reuters
Tue, 10/28/14 - 11:34 am
Daiichi Sankyo
FDA
bloodthinners
edoxaban
atrial fibrillation
Is Ambit Biosciences Getting Enough in Its Buyout?
Yahoo/24-7 Wall St
Mon, 09/29/14 - 01:53 pm
M&A
Ambit Biosciences
Daiichi Sankyo
Daiichi Sankyo to Buy Ambit to Boost Cancer Drug Pipeline
Bloomberg
Mon, 09/29/14 - 07:55 am
Daiichi Sankyo
Ambit Biosciences
M&A
Pages
« first
‹ previous
…
5
6
7
8
9
10
11
12
13
next ›
last »